Laser Genesis: What It Does for Redness, Pores and Texture

Laser Genesis is Cutera's name for a skin treatment — it is not a device of its own.

The name covers a protocol delivered from Cutera's xeo+, excel V+ and excel HR platforms, all of which carry the company's non-ablative 1064 nm Nd:YAG laser.

"Non-ablative" describes a laser that treats by heating tissue below the skin's surface rather than removing the surface itself.

Cutera describes the mechanism this way: gentle heating of the dermis, the skin's deeper layer, stimulates collagen remodeling and neocollagenesis, the formation of new collagen.

The company links that process to reductions in fine lines and redness.

Those are the maker's words, and this page keeps the attribution on them throughout.

Timing is the one concrete figure in Cutera's description: a full face takes about 15 minutes.

The cleared indications Cutera lists for its 1064 nm Laser Genesis treatment include:

• Wrinkles — the cleared wording names periocular (around the eyes) and perioral (around the mouth) wrinkles.
• Benign vascular lesions — "such as, but not limited to," in the cleared wording, rosacea, telangiectasias (small visible vessels), leg veins and spider veins.
• Red hypertrophic scars.
• Hair reduction.
• Warts.
• Mild-to-moderate inflammatory acne.

Two uses are missing from that list: smaller pores and smoother skin texture.

Neither appears among the cleared indications our research recorded from Cutera, and we could not confirm a cleared claim for either.

What Cutera offers instead is the collagen mechanism described above, which the maker ties to fine lines and redness — not a cleared claim about pores or texture.

When a menu promises pore results, ask what evidence stands behind the promise.

Redness has the most concrete numbers in the record, and they come from the American Academy of Dermatology's guidance on laser treatment for rosacea — lasers generally, not Laser Genesis by name.

The AAD says laser or light therapy is unlikely to be the only rosacea treatment; plans usually combine medication, gentle skin care and trigger avoidance.

For visible blood vessels, the AAD says most patients see a 50–75% reduction after 1–3 treatments, with results it says tend to last 3–5 years, though new vessels can form.

For general redness rather than individual vessels, small studies the AAD cites found most patients had only about a 20% reduction.

On skin tone, Cutera's materials describe the 1064 nm wavelength as "safe for all skin types and tones." That is the maker's claim, and the same company's safety information lists hyper- and hypopigmentation — skin turning darker or lighter — among possible adverse events.

Read the two together, and put your skin history on the table at the consultation.

Start with the gap: our research holds no verified price for Laser Genesis — no national figure, no manufacturer price, no survey average.

We will not dress one up as an "average cost."

The usual near-miss sources do not fill it either.

The American Society of Plastic Surgeons' 2025 statistics release does not report fees for minimally invasive procedures, so there is no current ASPS average fee to borrow for this category.

What the maker's materials show is the shape of the spend.

Cutera describes Laser Genesis as a series of quick treatments and states no number of sessions; the before-and-after captions on the company's own pages credit results to 3, 4, 5 and 7 sessions.

The total is the per-session price multiplied by the length of the series a practice recommends — which makes the session count the first number to pin down.

Treat any quote as that practice's number, not a market price.

Four questions to get in writing: which Cutera platform the treatment runs on, the per-session price, the total for the recommended series, and what each session includes.

Sessions: Cutera's pages state no specific number.

The company's own before-and-after photos show results credited to 3, 4, 5 and 7 sessions — a spread, not a protocol.

A practice that quotes a fixed course is quoting its own routine, so ask what the number is based on.

Duration is the bigger gap.

We could not confirm any figure for how long Laser Genesis results hold: our research pass found no manufacturer timeline and no independent trial that measured one.

A month count attached to the treatment anywhere else is one our research could not verify.

The honest questions for a provider are how long results have held in their patients and what maintenance they advise.

On pain, we found no data: our research holds no pain scores for Laser Genesis, neither from a trial nor from the maker.

Cutera's materials call the treatments quick, which is a claim about time, not comfort.

Ask the practice what the sensation is like and what comfort options it offers during the session.

On downtime, the marketing and the safety list tell two stories.

Cutera's materials describe the treatment as "without downtime" and as "a series of quick, no-downtime treatments" — both the company's phrases.

The same company's safety information lists possible adverse events that include redness, swelling and purpura, a purplish, bruise-like discoloration.

What your skin does in the hours after a session is the downtime question that matters, and the safety list is the more concrete guide to it.

Cutera's safety information for Laser Genesis lists these possible adverse events:

• Redness.
• Swelling.
• Purpura, a purplish, bruise-like discoloration.
• Hyperpigmentation and hypopigmentation — patches of skin turning darker or lighter than the skin around them.
• Burns.
• Blistering.
• Scarring.

The list carries no frequency figures: no rate for any of these events appears in the Cutera safety information our research reviewed.

Treat any percentage you see attached to Laser Genesis elsewhere as unverified in our research.

Pigment change is the entry to weigh against the maker's all-skin-types line.

The safety list names skin turning both darker and lighter, which is an explicit conversation to have if you have a history of pigment change, tan deeply, or are booking close to a summer of sun exposure.

An honest comparison runs on two layers: what each option is cleared for, and what its maker claims.

Our research holds no head-to-head trial data between these devices, so those two layers are what there is to work with.

IPL is not a laser.

The American Society of Plastic Surgeons defines intense pulsed light as a non-laser light treatment that emits many wavelengths at once, converted to heat to target pigment, blood vessels and hair follicles; BBL is Sciton's own brand of IPL.

Sciton says its BBL HEROic treats skin types I–V (not VI) for pigment, vascular redness, mild-to-moderate inflammatory acne and hair removal, with only its SkinTyte infrared mode described as usable on types V and VI — a narrower maker claim than Cutera's all-skin-types line.

Our IPL photofacial guide covers that treatment in depth.

Fractional non-ablative lasers treat the skin as a grid of microscopic zones rather than the whole surface at once.

Moxi, Sciton's fractionated non-ablative 1927 nm laser, is described by the maker as an 8–10-minute treatment with a recommended course of 2–4 sessions.

Solta's Fraxel pairs a 1550 nm wavelength, which the company lists for resurfacing that includes melasma, wrinkles around the eyes, acne scars and surgical scars, with a 1927 nm wavelength listed for actinic keratosis and pigmented lesions such as age spots and freckles; Solta says results may show after one treatment but up to five treatments may be appropriate, with a full face taking 20–25 minutes after about 60 minutes of topical numbing.

Our guides to laser resurfacing and Moxi cover both in depth.

Mapped against the cleared wording, the divisions are concrete.

Visible vessels and rosacea redness sit on Laser Genesis's cleared list and among IPL's targets.

Pigment sits with IPL, BBL and the resurfacing wavelengths — the Laser Genesis indications our research recorded do not name pigmented lesions.

Acne appears on Cutera's list, for mild-to-moderate inflammatory acne, and in Sciton's BBL description.

Wrinkles are on Cutera's list for the eye and mouth areas specifically, and in Solta's Fraxel listing for around the eyes.

Which device suits which face is a licensed provider's call after an examination; a page can narrow the menu, not make the choice.

Start with who is allowed to treat you, which is state law.

AmSpa, a med spa trade association, says injecting botulinum toxin is the practice of medicine because a prescription drug is being used to affect living tissue, so it must be done by a physician, an independent-practice NP or another licensed professional acting within their scope, under rules that vary by state.

Laser Genesis is a laser treatment rather than an injectable, so the direct questions are who operates the device, what that person's license is, and what training they have on this specific platform.

Ask which machine the menu item runs on.

Laser Genesis is Cutera's treatment, delivered from the company's xeo+, excel V+ and excel HR platforms, so a practice offering it should be able to name the platform in the room and the person trained on it.

Read the gallery the way the captions do.

Cutera's own before-and-after captions state how many sessions produced each result — 3, 4, 5 and 7 in the company's examples.

And under the FTC's endorsement guides, a result shown in an ad is read as representative of what consumers generally achieve; an advertiser whose results are not typical must clearly disclose the results consumers can generally expect, and a "results not typical" disclaimer alone is generally insufficient.

Screening is part of quality.

A practice should ask about pregnancy, skin-cancer treatment and recent tanning before treatment, because the maker's own contraindication list draws lines there.

If nobody asks, read that as information about the practice.

Finally, money: the per-session price and the total for the recommended series, in writing, before you book.

Our checklist for how to choose a med spa covers the questions that travel to any treatment, from who owns the practice to what to get in writing.